Jane Street Group LLC Buys 103,871 Shares of Owens & Minor, Inc. (NYSE:OMI)

Jane Street Group LLC increased its stake in Owens & Minor, Inc. (NYSE:OMI) by 126.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 186,280 shares of the company’s stock after acquiring an additional 103,871 shares during the period. Jane Street Group LLC owned about 0.24% of Owens & Minor worth $2,923,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of OMI. Quarry LP boosted its holdings in shares of Owens & Minor by 290.1% during the second quarter. Quarry LP now owns 2,099 shares of the company’s stock worth $28,000 after purchasing an additional 1,561 shares during the period. DekaBank Deutsche Girozentrale lifted its holdings in Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock worth $43,000 after buying an additional 1,356 shares during the period. Innealta Capital LLC bought a new stake in shares of Owens & Minor in the 2nd quarter worth approximately $43,000. Blue Trust Inc. grew its position in shares of Owens & Minor by 176.8% in the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock worth $44,000 after buying an additional 1,780 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its stake in shares of Owens & Minor by 100.6% during the second quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company’s stock valued at $82,000 after buying an additional 3,044 shares during the period. 98.04% of the stock is currently owned by hedge funds and other institutional investors.

Owens & Minor Trading Down 0.8 %

NYSE:OMI opened at $12.52 on Friday. The stock has a market cap of $965.40 million, a price-to-earnings ratio of -19.26, a PEG ratio of 0.48 and a beta of 0.42. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The company’s 50 day moving average price is $13.26 and its 200-day moving average price is $14.59. Owens & Minor, Inc. has a 52 week low of $11.42 and a 52 week high of $28.35.

Owens & Minor (NYSE:OMI) last posted its earnings results on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.44 EPS. On average, equities research analysts forecast that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.

Insider Buying and Selling at Owens & Minor

In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the sale, the chief financial officer now directly owns 130,822 shares in the company, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on OMI. UBS Group reduced their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. StockNews.com cut Owens & Minor from a “buy” rating to a “hold” rating in a research report on Monday, August 26th. Barclays lowered their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Robert W. Baird decreased their price objective on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. Finally, Citigroup dropped their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $18.50.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.